Total Payments
$14,918
2024 Payments
$2,310
Companies
46
Transactions
1,062
Medicare Patients
8,508
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$14,799 (99.2%)
Education$119.32 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,799 | 1,057 | 99.2% |
| Education | $119.32 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,549 | 250 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,651 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,054 | 80 | $0 (2024) |
| Philips Electronics North America Corporation | $899.91 | 55 | $0 (2023) |
| Mylan Specialty L.P. | $872.36 | 59 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $719.06 | 49 | $0 (2024) |
| GENZYME CORPORATION | $453.01 | 29 | $0 (2024) |
| Genentech USA, Inc. | $451.17 | 37 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $405.75 | 23 | $0 (2024) |
| Grifols USA, LLC | $394.99 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,310 | 164 | GlaxoSmithKline, LLC. ($358.71) |
| 2023 | $2,368 | 140 | Philips Electronics North America Corporation ($356.30) |
| 2022 | $2,447 | 156 | Philips Electronics North America Corporation ($335.76) |
| 2021 | $1,495 | 114 | GlaxoSmithKline, LLC. ($364.11) |
| 2020 | $1,712 | 130 | GlaxoSmithKline, LLC. ($392.70) |
| 2019 | $1,598 | 138 | AstraZeneca Pharmaceuticals LP ($310.37) |
| 2018 | $1,351 | 111 | GlaxoSmithKline, LLC. ($289.07) |
| 2017 | $1,637 | 109 | GlaxoSmithKline, LLC. ($393.36) |
All Payment Transactions
1,062 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Allergy/Immunology | ||||||
| 12/17/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Medical Device | ||||||
| 12/13/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.18 | General |
| Category: HFCWO | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.94 | General |
| Category: HFCWO | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/15/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Medical Device | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Pulmonology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Narcoplepsy | ||||||
| 11/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,153 | 3,460 | $1.6M | $212,944 |
| 2022 | 22 | 2,027 | 3,514 | $1.8M | $242,959 |
| 2021 | 24 | 2,410 | 4,502 | $2.8M | $349,020 |
| 2020 | 23 | 1,918 | 3,085 | $1.7M | $200,280 |
Total Patients
8,508
Total Services
14,561
Medicare Billing
$1.0M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 395 | 932 | $647,434 | $96,964 | 15.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 127 | 127 | $167,640 | $23,236 | 13.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 349 | 776 | $195,552 | $18,197 | 9.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 86 | 99 | $126,276 | $12,910 | 10.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 62 | $57,660 | $9,228 | 16.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 157 | 159 | $59,466 | $8,125 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 116 | $54,752 | $7,125 | 13.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 148 | $21,460 | $6,934 | 32.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 157 | $22,765 | $6,800 | 29.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 157 | 159 | $46,428 | $6,237 | 13.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 157 | 159 | $68,370 | $5,429 | 7.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 76 | 85 | $12,124 | $4,274 | 35.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 92 | 100 | $40,600 | $2,807 | 6.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 13 | 14 | $14,504 | $2,201 | 15.2% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 157 | 159 | $27,984 | $2,131 | 7.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 12 | 12 | $3,504 | $121.68 | 3.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 12 | 12 | $5,160 | $104.28 | 2.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 12 | 12 | $4,488 | $90.36 | 2.0% |
| 94200 | Test to measure largest amount of air breathed in an out | Facility | 2023 | 12 | 12 | $2,112 | $27.60 | 1.3% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 158 | 160 | $320.00 | $3.68 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 334 | 818 | $568,060 | $86,725 | 15.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 119 | 288 | $187,200 | $25,445 | 13.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 284 | 655 | $165,060 | $15,818 | 9.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 33 | 73 | $184,544 | $13,924 | 7.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 77 | 77 | $101,640 | $13,709 | 13.5% |
About Dr. Prashant Patel, MD
Dr. Prashant Patel, MD is a Sleep Medicine healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982806915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prashant Patel, MD has received a total of $14,918 in payments from pharmaceutical and medical device companies, with $2,310 received in 2024. These payments were reported across 1,062 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,799).
As a Medicare-enrolled provider, Patel has provided services to 8,508 Medicare beneficiaries, totaling 14,561 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Critical Care Medicine
- Location Bridgewater, NJ
- Active Since 06/01/2007
- Last Updated 04/16/2013
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1982806915
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,029
- DUPIXENT (Biological) $883.52
- (8874) inCourage (Device) $812.98
- NUCALA (Biological) $659.19
- OFEV (Drug) $616.06
- SYMBICORT (Drug) $530.01
- Yupelri (Drug) $478.56
- SUNOSI (Drug) $409.33
- FASENRA (Biological) $402.40
- Xolair (Biological) $368.22
- Prolastin-C Liquid (Biological) $358.84
- ELIQUIS (Drug) $344.48
- TEZSPIRE (Biological) $342.94
- YUPELRI (Drug) $321.24
- GLASSIA (Biological) $313.19
- LONHALA MAGNAIR (Drug) $290.17
- ANORO (Drug) $282.25
- (AK6) Vest Therapy (Device) $278.57
- CHARTIS CATHETER (Device) $254.48
- INSPIRE (Device) $245.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.